SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,300,129 | -7.3% | 119,700 | +1.1% | 0.00% | +50.0% |
| Q2 2023 | $3,559,104 | -15.7% | 118,400 | +1.5% | 0.00% | -33.3% |
| Q1 2023 | $4,224,418 | -8.3% | 116,600 | -9.8% | 0.00% | 0.0% |
| Q4 2022 | $4,608,564 | +7.5% | 129,200 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $4,289,000 | +18.0% | 126,700 | +0.8% | 0.00% | +50.0% |
| Q2 2022 | $3,635,000 | -10.5% | 125,700 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,063,000 | +19.0% | 125,700 | +7.3% | 0.00% | 0.0% |
| Q4 2021 | $3,415,000 | +9.3% | 117,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $3,123,000 | -12.6% | 117,100 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $3,575,000 | +13.4% | 116,100 | -3.6% | 0.00% | 0.0% |
| Q1 2021 | $3,152,000 | +5.2% | 120,400 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $2,997,000 | +20.7% | 119,100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,482,000 | -10.8% | 119,100 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $2,781,000 | +52.0% | 117,100 | +15.1% | 0.00% | 0.0% |
| Q1 2020 | $1,830,000 | -23.1% | 101,700 | +1.3% | 0.00% | 0.0% |
| Q4 2019 | $2,381,000 | -11.9% | 100,400 | +2.0% | 0.00% | -33.3% |
| Q3 2019 | $2,704,000 | -16.0% | 98,400 | +1.1% | 0.00% | 0.0% |
| Q2 2019 | $3,220,000 | -3.5% | 97,300 | +2.2% | 0.00% | -25.0% |
| Q1 2019 | $3,336,000 | +8.8% | 95,200 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $3,066,000 | -32.5% | 92,300 | +2.3% | 0.00% | -20.0% |
| Q3 2018 | $4,542,000 | -15.9% | 90,200 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $5,398,000 | +33.3% | 90,200 | +2.0% | 0.01% | +20.0% |
| Q1 2018 | $4,049,000 | +17.6% | 88,400 | +2.3% | 0.01% | +25.0% |
| Q4 2017 | $3,443,000 | +3.1% | 86,400 | +3.5% | 0.00% | 0.0% |
| Q3 2017 | $3,340,000 | -7.2% | 83,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,599,000 | +76.1% | 83,500 | +27.9% | 0.00% | +33.3% |
| Q1 2017 | $2,044,000 | +28.1% | 65,300 | +3.3% | 0.00% | 0.0% |
| Q4 2016 | $1,596,000 | +2.1% | 63,200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,563,000 | +18.1% | 63,200 | -2.8% | 0.00% | +50.0% |
| Q2 2016 | $1,324,000 | +59.5% | 65,000 | +15.5% | 0.00% | 0.0% |
| Q1 2016 | $830,000 | +34.3% | 56,300 | +22.4% | 0.00% | +100.0% |
| Q4 2015 | $618,000 | -4.2% | 46,000 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $645,000 | -4.6% | 46,000 | +15.6% | 0.00% | 0.0% |
| Q2 2015 | $676,000 | – | 39,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |